Tandem Diabetes Care Inc (NAS:TNDM)
$ 33.81 1.71 (5.33%) Market Cap: 2.11 Bil Enterprise Value: 1.98 Bil PE Ratio: 0 PB Ratio: 8.85 GF Score: 82/100

Tandem Diabetes Care Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2019 / 12:00PM GMT
Release Date Price: $71.97 (+0.77%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

All right. Good morning, everybody, and thanks for joining us for the last day here at the Barclays Global Healthcare Conference. I'm Kristen Stewart, the Medical Supplies and Device Analyst, and I'm very pleased to have the team from Tandem Diabetes here with us today.

So with me on stage, we have Leigh Vosseller, the company's CFO; we have Susan Morrison, IRM, CAO; and then John Sheridan, who is the President and CEO of the company. Fourteen days in, I guess, at your new role. We're excited to hear your takes here. So we're going to do a very, very quick presentation, and then dive right into Q&A. So let's start with you, John.

John F. Sheridan
Tandem Diabetes Care, Inc. - President & CEO

Sure. Let's go. Okay. Well, thank you very much for coming today. I'm John Sheridan, I'm the newly minted CEO for Tandem.

I'd like to start off by just saying, I'm very fortunate to be in this role. We have a great story at Tandem, but behind that there's a great team.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot